273 related articles for article (PubMed ID: 21861817)
1. Evolving molecular mechanism-based strategies for control of hepatocellular carcinoma.
Sato K; Mori M
Curr Med Chem; 2011; 18(28):4375-88. PubMed ID: 21861817
[TBL] [Abstract][Full Text] [Related]
2. Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma.
Zhu AX
Cancer; 2008 Jan; 112(2):250-9. PubMed ID: 18041064
[TBL] [Abstract][Full Text] [Related]
3. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
Pang RW; Poon RT
Oncology; 2007; 72 Suppl 1():30-44. PubMed ID: 18087180
[TBL] [Abstract][Full Text] [Related]
4. Emerging targeted strategies in advanced hepatocellular carcinoma.
Finn RS
Semin Liver Dis; 2013 Feb; 33 Suppl 1():S11-9. PubMed ID: 23457035
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapy of hepatocellular cancer.
Wysocki PJ
Expert Opin Investig Drugs; 2010 Feb; 19(2):265-74. PubMed ID: 20074016
[TBL] [Abstract][Full Text] [Related]
6. Pathways and targets in hepatocellular carcinoma.
Psyrri A; Arkadopoulos N; Vassilakopoulou M; Smyrniotis V; Dimitriadis G
Expert Rev Anticancer Ther; 2012 Oct; 12(10):1347-57. PubMed ID: 23176622
[TBL] [Abstract][Full Text] [Related]
7. Systemic treatment of hepatocellular carcinoma: dawn of a new era?
Zhu AX
Ann Surg Oncol; 2010 May; 17(5):1247-56. PubMed ID: 20405329
[TBL] [Abstract][Full Text] [Related]
8. Current status of molecularly targeted therapy for hepatocellular carcinoma: clinical practice.
Kudo M
Int J Clin Oncol; 2010 Jun; 15(3):242-55. PubMed ID: 20509038
[TBL] [Abstract][Full Text] [Related]
9. [Hepatocellular carcinoma].
Kondo S; Ueno H; Morizane C; Okusaka T
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1219-23. PubMed ID: 20647702
[TBL] [Abstract][Full Text] [Related]
10. Systemic therapies in hepatocellular carcinoma.
Wörns MA; Weinmann A; Schuchmann M; Galle PR
Dig Dis; 2009; 27(2):175-88. PubMed ID: 19546557
[TBL] [Abstract][Full Text] [Related]
11. Molecularly targeted therapy in hepatocellular carcinoma.
Huynh H
Biochem Pharmacol; 2010 Sep; 80(5):550-60. PubMed ID: 20371362
[TBL] [Abstract][Full Text] [Related]
12. Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma.
Zhu AX
Expert Opin Investig Drugs; 2010 May; 19(5):663-72. PubMed ID: 20367287
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathogenesis and targeted therapy of hepatocellular carcinoma.
Zender L; Kubicka S
Onkologie; 2008 Oct; 31(10):550-5. PubMed ID: 18854656
[TBL] [Abstract][Full Text] [Related]
14. Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
Kudo M
Dig Dis; 2011; 29(3):289-302. PubMed ID: 21829020
[TBL] [Abstract][Full Text] [Related]
15. Molecular targeted therapy for hepatocellular carcinoma.
Thomas M
J Gastroenterol; 2009; 44 Suppl 19():136-41. PubMed ID: 19148808
[TBL] [Abstract][Full Text] [Related]
16. Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science.
Tanaka S; Arii S
Int J Clin Oncol; 2010 Jun; 15(3):235-41. PubMed ID: 20505971
[TBL] [Abstract][Full Text] [Related]
17. Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer.
Höpfner M; Schuppan D; Scherübl H
World J Gastroenterol; 2008 Jan; 14(1):1-14. PubMed ID: 18176955
[TBL] [Abstract][Full Text] [Related]
18. Novel inhibitors in development for hepatocellular carcinoma.
Wörns MA; Galle PR
Expert Opin Investig Drugs; 2010 May; 19(5):615-29. PubMed ID: 20374038
[TBL] [Abstract][Full Text] [Related]
19. Molecular targeted therapy for hepatocellular carcinoma: current and future.
Shin JW; Chung YH
World J Gastroenterol; 2013 Oct; 19(37):6144-55. PubMed ID: 24115810
[TBL] [Abstract][Full Text] [Related]
20. MET inhibitors for treatment of advanced hepatocellular carcinoma: A review.
Qi XS; Guo XZ; Han GH; Li HY; Chen J
World J Gastroenterol; 2015 May; 21(18):5445-53. PubMed ID: 25987766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]